Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Notable open interest changes for May 6th » 08:55
05/06/21
05/06
08:55
05/06/21
08:55
UBER

Uber

$51.21 /

-1.79 (-3.38%)

, PTON

Peloton

$82.61 /

-14.26 (-14.72%)

, AAPL

Apple

$128.16 /

+0.22 (+0.17%)

, AMD

AMD

$77.85 /

-0.77 (-0.98%)

Wednesday's total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UBER Uber
$51.21 /

-1.79 (-3.38%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

AAPL Apple
$128.16 /

+0.22 (+0.17%)

AMD AMD
$77.85 /

-0.77 (-0.98%)

UBER Uber
$51.21 /

-1.79 (-3.38%)

07:42 Today JPMorgan
JPMorgan boosts Uber target to $74 on continued mobility recovery
07:31 Today Deutsche Bank
Uber price target raised to $85 from $82 at Deutsche Bank
06:09 Today Piper Sandler
Uber price target lowered to $55 from $58 at Piper Sandler
05/05/21 Cowen
Department of Labor comments incrementally encouraging for Uber/Lyft, says Cowen
PTON Peloton
$82.61 /

-14.26 (-14.72%)

05/05/21 BofA
Peloton downgraded to Neutral after 'thesis changing' recalls at BofA
05/05/21 BofA
Peloton downgraded to Neutral from Buy at BofA
05/05/21 BMO Capital
BMO Capital continues to worry Peloton shares will catch down to fundamentals
05/05/21 JPMorgan
JPMorgan sees Peloton shares remaining under pressure
AAPL Apple
$128.16 /

+0.22 (+0.17%)

05/05/21 Bernstein
Bernstein sees modest financial consequence to Apple even with adverse rulings
05/04/21 Morgan Stanley
Apple Services estimate trimmed at Morgan Stanley after April App Store data
05/04/21 Needham
Cirrus Logic upgraded to Buy from Hold at Needham
05/03/21 Evercore ISI
Apple's App Store developer revenue growth slowed in April, says Evercore ISI
AMD AMD
$77.85 /

-0.77 (-0.98%)

04/28/21 Northland
AMD price target raised to $116 from $96 at Northland
04/28/21 Susquehanna
AMD price target raised to $125 from $115 at Susquehanna
04/28/21 Raymond James
AMD price target raised to $110 from $100 at Raymond James
04/28/21 Mizuho
AMD price target raised to $107 from $105 at Mizuho
UBER Uber
$51.21 /

-1.79 (-3.38%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

AAPL Apple
$128.16 /

+0.22 (+0.17%)

AMD AMD
$77.85 /

-0.77 (-0.98%)

  • 08
    Jan
UBER Uber
$51.21 /

-1.79 (-3.38%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

AAPL Apple
$128.16 /

+0.22 (+0.17%)

AMD AMD
$77.85 /

-0.77 (-0.98%)

UBER Uber
$51.21 /

-1.79 (-3.38%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

AAPL Apple
$128.16 /

+0.22 (+0.17%)

AMD AMD
$77.85 /

-0.77 (-0.98%)

UBER Uber
$51.21 /

-1.79 (-3.38%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

AAPL Apple
$128.16 /

+0.22 (+0.17%)

AMD AMD
$77.85 /

-0.77 (-0.98%)

Hot Stocks
Cedar Realty Trust partners with Asland Capital, Goldman Sachs Urban Investment » 08:53
05/06/21
05/06
08:53
05/06/21
08:53
CDR

Cedar Realty Trust

$15.64 /

-0.3 (-1.88%)

, GS

Goldman Sachs

$357.48 /

+7.77 (+2.22%)

Cedar Realty Trust (CDR),…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CDR Cedar Realty Trust
$15.64 /

-0.3 (-1.88%)

GS Goldman Sachs
$357.48 /

+7.77 (+2.22%)

CDR Cedar Realty Trust
$15.64 /

-0.3 (-1.88%)

03/04/21 B. Riley Securities
Cedar Realty Trust price target raised to $19 from $15 at B. Riley Securities
11/10/20 Compass Point
Compass Point upgrades four retail REITs to Neutral after Pfizer 'game changer'
11/09/20 Compass Point
Cedar Realty Trust upgraded to Neutral from Sell at Compass Point
GS Goldman Sachs
$357.48 /

+7.77 (+2.22%)

04/23/21 Citi
Goldman Sachs price target raised to $410 from $390 at Citi
04/21/21 Berenberg
Goldman Sachs price target raised to $330 from $270 at Berenberg
04/18/21 BMO Capital
OneMain Holdings downgraded to Market Perform from Outperform at BMO Capital
04/16/21 BMO Capital
Goldman Sachs price target raised to $432 from $409 at BMO Capital
CDR Cedar Realty Trust
$15.64 /

-0.3 (-1.88%)

GS Goldman Sachs
$357.48 /

+7.77 (+2.22%)

GS Goldman Sachs
$357.48 /

+7.77 (+2.22%)

GS Goldman Sachs
$357.48 /

+7.77 (+2.22%)

GS Goldman Sachs
$357.48 /

+7.77 (+2.22%)

Conference/Events
Levy Economics Institute of Bard College to hold a virtual conference » 08:25
05/06/21
05/06
08:25
05/06/21
08:25
GS

Goldman Sachs

$357.48 /

+7.77 (+2.22%)

, JPM

JPMorgan

$157.52 /

+2.0101 (+1.29%)

, TRI

Thomson Reuters

$95.81 /

-0.92 (-0.95%)

29th Annual Hyman P.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GS Goldman Sachs
$357.48 /

+7.77 (+2.22%)

JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

TRI Thomson Reuters
$95.81 /

-0.92 (-0.95%)

GS Goldman Sachs
$357.48 /

+7.77 (+2.22%)

04/23/21 Citi
Goldman Sachs price target raised to $410 from $390 at Citi
04/21/21 Berenberg
Goldman Sachs price target raised to $330 from $270 at Berenberg
04/18/21 BMO Capital
OneMain Holdings downgraded to Market Perform from Outperform at BMO Capital
04/16/21 BMO Capital
Goldman Sachs price target raised to $432 from $409 at BMO Capital
JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

06:21 Today JMP Securities
Walker & Dunlop price target raised to $130 from $70 at JMP Securities
04/30/21 Wells Fargo
JPMorgan price target raised to $195 from $190 at Wells Fargo
04/27/21 Atlantic Equities
JPMorgan downgraded to Neutral from Overweight at Atlantic Equities
04/15/21 DA Davidson
JPMorgan price target raised to $182 from $179 at DA Davidson
TRI Thomson Reuters
$95.81 /

-0.92 (-0.95%)

05/05/21 Scotiabank
Thomson Reuters price target raised to C$128 from C$122 at Scotiabank
05/05/21 TD Securities
Thomson Reuters price target raised to C$130 from C$125 at TD Securities
05/05/21 Canaccord
Thomson Reuters price target raised to $102 from $95 at Canaccord
05/04/21 CIBC
Thomson Reuters downgraded to Neutral from Outperformer at CIBC
GS Goldman Sachs
$357.48 /

+7.77 (+2.22%)

JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

TRI Thomson Reuters
$95.81 /

-0.92 (-0.95%)

GS Goldman Sachs
$357.48 /

+7.77 (+2.22%)

JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

GS Goldman Sachs
$357.48 /

+7.77 (+2.22%)

JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

GS Goldman Sachs
$357.48 /

+7.77 (+2.22%)

JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

Options
Pfizer put buyer realizes 156% same-day gains » 08:00
05/06/21
05/06
08:00
05/06/21
08:00
PFE

Pfizer

$39.58 /

-0.39 (-0.98%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$39.58 /

-0.39 (-0.98%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

06:02 Today Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
PFE Pfizer
$39.58 /

-0.39 (-0.98%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

Hot Stocks
Pfizer, BioNTech to provide COVID vaccine doses at 2020 Tokyo Games » 06:34
05/06/21
05/06
06:34
05/06/21
06:34
PFE

Pfizer

$39.58 /

-0.39 (-0.98%)

, BNTX

BioNTech

$170.68 /

-6.22 (-3.52%)

Pfizer (PFE) and BioNTech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$39.58 /

-0.39 (-0.98%)

BNTX BioNTech
$170.68 /

-6.22 (-3.52%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

06:02 Today Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
BNTX BioNTech
$170.68 /

-6.22 (-3.52%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
PFE Pfizer
$39.58 /

-0.39 (-0.98%)

  • 23
    Jul
PFE Pfizer
$39.58 /

-0.39 (-0.98%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

BNTX BioNTech
$170.68 /

-6.22 (-3.52%)

Recommendations
Walker & Dunlop price target raised to $130 from $70 at JMP Securities » 06:21
05/06/21
05/06
06:21
05/06/21
06:21
WD

Walker & Dunlop

$113.53 /

+0.465 (+0.41%)

, JPM

JPMorgan

$157.52 /

+2.0101 (+1.29%)

, WFC

Wells Fargo

$45.84 /

+0.1 (+0.22%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WFC Wells Fargo
$45.84 /

+0.1 (+0.22%)

WD Walker & Dunlop
$113.53 /

+0.465 (+0.41%)

JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

WD Walker & Dunlop
$113.53 /

+0.465 (+0.41%)

02/10/21 Wedbush
Walker & Dunlop price target raised to $112 from $98 at Wedbush
02/05/21 Keefe Bruyette
Walker & Dunlop price target raised to $90 from $85 at Keefe Bruyette
12/11/20 Wedbush
Walker & Dunlop price target raised to $98 from $78 at Wedbush
11/06/20 Wolfe Research
Walker & Dunlop initiated with an Outperform at Wolfe Research
JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

04/30/21 Wells Fargo
JPMorgan price target raised to $195 from $190 at Wells Fargo
04/27/21 Atlantic Equities
JPMorgan downgraded to Neutral from Overweight at Atlantic Equities
04/15/21 DA Davidson
JPMorgan price target raised to $182 from $179 at DA Davidson
04/15/21 RBC Capital
JPMorgan price target raised to $160 from $150 at RBC Capital
WFC Wells Fargo
$45.84 /

+0.1 (+0.22%)

05/03/21 JPMorgan
Wells Fargo price target raised to $47 from $41.50 at JPMorgan
04/26/21 Deutsche Bank
Wells Fargo price target raised to $48 from $45 at Deutsche Bank
04/15/21 Argus
Wells Fargo price target raised to $47 from $37 at Argus
04/15/21 Evercore ISI
Wells Fargo price target raised to $48 from $38 at Evercore ISI
WFC Wells Fargo
$45.84 /

+0.1 (+0.22%)

WD Walker & Dunlop
$113.53 /

+0.465 (+0.41%)

JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

WFC Wells Fargo
$45.84 /

+0.1 (+0.22%)

WD Walker & Dunlop
$113.53 /

+0.465 (+0.41%)

JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

WFC Wells Fargo
$45.84 /

+0.1 (+0.22%)

JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

Periodicals
JPMorgan to move another $200B to European hub, Bloomberg reports » 06:16
05/06/21
05/06
06:16
05/06/21
06:16
JPM

JPMorgan

$157.52 /

+2.0101 (+1.29%)

JPMorgan is expecting to…

JPMorgan is expecting to move a similar amount of assets to its balance sheet in Frankfurt as it did last year to adapt to post-Brexit Europe, Steven Arons of Bloomberg reports, citing the company's annual report. Last year, the bank's European unit increased by about $216B, the report included, according to Arons. Reference Link

ShowHide Related Items >><<
JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

04/30/21 Wells Fargo
JPMorgan price target raised to $195 from $190 at Wells Fargo
04/27/21 Atlantic Equities
JPMorgan downgraded to Neutral from Overweight at Atlantic Equities
04/15/21 DA Davidson
JPMorgan price target raised to $182 from $179 at DA Davidson
04/15/21 RBC Capital
JPMorgan price target raised to $160 from $150 at RBC Capital
JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

Downgrade
Pfizer downgraded to Neutral from Buy at Mizuho » 06:02
05/06/21
05/06
06:02
05/06/21
06:02
PFE

Pfizer

$39.58 /

-0.39 (-0.98%)

Mizuho analyst Vamil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$39.58 /

-0.39 (-0.98%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
PFE Pfizer
$39.58 /

-0.39 (-0.98%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

Conference/Events
European Society for Medical Oncology to hold a virtual meeting » 04:55
05/06/21
05/06
04:55
05/06/21
04:55
PFE

Pfizer

$39.58 /

-0.39 (-0.98%)

, NVS

Novartis

$86.51 /

+0.87 (+1.02%)

, LLY

Eli Lilly

$192.85 /

+4.62 (+2.45%)

, GILD

Gilead

$66.52 /

+0.87 (+1.33%)

, SNY

Sanofi

$50.56 /

+0.12 (+0.24%)

, RHHBY

Roche

$40.87 /

+0.14 (+0.34%)

, EXAS

Exact Sciences

$110.59 /

-5.29 (-4.57%)

, NTRA

Natera

$104.96 /

-1.99 (-1.86%)

, SGEN

Seagen

$135.19 /

-0.96 (-0.71%)

ESMO Breast Cancer…

ESMO Breast Cancer Virtual Congress 2021 will be held on May 5-8. Webcast Link

ShowHide Related Items >><<
SNY Sanofi
$50.56 /

+0.12 (+0.24%)

SGEN Seagen
$135.19 /

-0.96 (-0.71%)

RHHBY Roche
$40.87 /

+0.14 (+0.34%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

NVS Novartis
$86.51 /

+0.87 (+1.02%)

NTRA Natera
$104.96 /

-1.99 (-1.86%)

LLY Eli Lilly
$192.85 /

+4.62 (+2.45%)

GILD Gilead
$66.52 /

+0.87 (+1.33%)

EXAS Exact Sciences
$110.59 /

-5.29 (-4.57%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
NVS Novartis
$86.51 /

+0.87 (+1.02%)

04/28/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 85 at JPMorgan
04/28/21 Oddo BHF
Novartis upgraded to Outperform from Neutral at Oddo BHF
04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
LLY Eli Lilly
$192.85 /

+4.62 (+2.45%)

04/28/21 Mizuho
Eli Lilly price target lowered to $216 from $228 at Mizuho
04/28/21 Barclays
Eli Lilly price target lowered to $227 from $232 at Barclays
04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
GILD Gilead
$66.52 /

+0.87 (+1.33%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
SNY Sanofi
$50.56 /

+0.12 (+0.24%)

04/30/21 Deutsche Bank
Sanofi price target raised to EUR 75 from EUR 70 at Deutsche Bank
04/29/21 Barclays
Sanofi price target raised to EUR 90 from EUR 85 at Barclays
04/28/21 Stifel
Protalix, Sanofi updates may signal headwinds for Avrobio, Amicus, says Stifel
04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
RHHBY Roche
$40.87 /

+0.14 (+0.34%)

05/05/21 BTIG
Mereo BioPharma initiated with a Buy at BTIG
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
EXAS Exact Sciences
$110.59 /

-5.29 (-4.57%)

05/05/21 Craig-Hallum
Exact Sciences price target lowered to $144 from $161 at Craig-Hallum
05/05/21 BTIG
Exact Sciences price target lowered to $155 from $175 at BTIG
02/18/21 Baird
Exact Sciences price target lowered to $163 from $169 at Baird
02/17/21 Stifel
Exact Sciences price target raised to $165 from $150 at Stifel
NTRA Natera
$104.96 /

-1.99 (-1.86%)

04/22/21 SVB Leerink
CMS coverage determination a positive for Natera, says SVB Leerink
03/10/21 Piper Sandler
Natera, Genentech start Phase 3 trial using Signatera, says Piper Sandler
02/26/21 Piper Sandler
Natera price target raised to $150 from $127 at Piper Sandler
01/27/21 Truist
Natera initiated with a Buy at Truist
SGEN Seagen
$135.19 /

-0.96 (-0.71%)

04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
SNY Sanofi
$50.56 /

+0.12 (+0.24%)

SGEN Seagen
$135.19 /

-0.96 (-0.71%)

RHHBY Roche
$40.87 /

+0.14 (+0.34%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

NVS Novartis
$86.51 /

+0.87 (+1.02%)

NTRA Natera
$104.96 /

-1.99 (-1.86%)

LLY Eli Lilly
$192.85 /

+4.62 (+2.45%)

GILD Gilead
$66.52 /

+0.87 (+1.33%)

EXAS Exact Sciences
$110.59 /

-5.29 (-4.57%)

  • 11
    Sep
SNY Sanofi
$50.56 /

+0.12 (+0.24%)

RHHBY Roche
$40.87 /

+0.14 (+0.34%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

NVS Novartis
$86.51 /

+0.87 (+1.02%)

LLY Eli Lilly
$192.85 /

+4.62 (+2.45%)

GILD Gilead
$66.52 /

+0.87 (+1.33%)

SNY Sanofi
$50.56 /

+0.12 (+0.24%)

SGEN Seagen
$135.19 /

-0.96 (-0.71%)

RHHBY Roche
$40.87 /

+0.14 (+0.34%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

NVS Novartis
$86.51 /

+0.87 (+1.02%)

NTRA Natera
$104.96 /

-1.99 (-1.86%)

LLY Eli Lilly
$192.85 /

+4.62 (+2.45%)

GILD Gilead
$66.52 /

+0.87 (+1.33%)

EXAS Exact Sciences
$110.59 /

-5.29 (-4.57%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

LLY Eli Lilly
$192.85 /

+4.62 (+2.45%)

GILD Gilead
$66.52 /

+0.87 (+1.33%)

Conference/Events
Levy Economics Institute of Bard College to hold a virtual conference » 04:55
05/06/21
05/06
04:55
05/06/21
04:55
GS

Goldman Sachs

$357.48 /

+7.77 (+2.22%)

, JPM

JPMorgan

$157.52 /

+2.0101 (+1.29%)

, TRI

Thomson Reuters

$95.81 /

-0.92 (-0.95%)

29th Annual Hyman P.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRI Thomson Reuters
$95.81 /

-0.92 (-0.95%)

JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

GS Goldman Sachs
$357.48 /

+7.77 (+2.22%)

GS Goldman Sachs
$357.48 /

+7.77 (+2.22%)

04/23/21 Citi
Goldman Sachs price target raised to $410 from $390 at Citi
04/21/21 Berenberg
Goldman Sachs price target raised to $330 from $270 at Berenberg
04/18/21 BMO Capital
OneMain Holdings downgraded to Market Perform from Outperform at BMO Capital
04/16/21 BMO Capital
Goldman Sachs price target raised to $432 from $409 at BMO Capital
JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

04/30/21 Wells Fargo
JPMorgan price target raised to $195 from $190 at Wells Fargo
04/27/21 Atlantic Equities
JPMorgan downgraded to Neutral from Overweight at Atlantic Equities
04/15/21 DA Davidson
JPMorgan price target raised to $182 from $179 at DA Davidson
04/15/21 RBC Capital
JPMorgan price target raised to $160 from $150 at RBC Capital
TRI Thomson Reuters
$95.81 /

-0.92 (-0.95%)

05/05/21 Scotiabank
Thomson Reuters price target raised to C$128 from C$122 at Scotiabank
05/05/21 TD Securities
Thomson Reuters price target raised to C$130 from C$125 at TD Securities
05/05/21 Canaccord
Thomson Reuters price target raised to $102 from $95 at Canaccord
05/04/21 CIBC
Thomson Reuters downgraded to Neutral from Outperformer at CIBC
TRI Thomson Reuters
$95.81 /

-0.92 (-0.95%)

JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

GS Goldman Sachs
$357.48 /

+7.77 (+2.22%)

JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

GS Goldman Sachs
$357.48 /

+7.77 (+2.22%)

JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

GS Goldman Sachs
$357.48 /

+7.77 (+2.22%)

JPM JPMorgan
$157.52 /

+2.0101 (+1.29%)

GS Goldman Sachs
$357.48 /

+7.77 (+2.22%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.